Induction of ovulation in quarter horse mares through the use of deslorelin acetate and human chorionic gonadotrophin (hCG)
AUTOR(ES)
Figueiredo, Tatiana, Paiva, Roman, Kozicki, Luiz Ernandes, Kaercher, Fernanda, Weiss, Romildo Romualdo, Santos, Ivo Walter dos, Muradas, Priscilla Ricabone
FONTE
Brazilian Archives of Biology and Technology
DATA DE PUBLICAÇÃO
2011-06
RESUMO
The aim this study was to compare two protocols of induction for ovulation by desloreline acetate and hCG in Quarter Horse mares. The choice of the animals was based on the observations by the estrus, by rectal palpation of the ovaries and by ultrassonography of the follicular dynamics. After estrus detection and follicle control, the measurement of the follicles and the classification of uterus were carried out. The animals that had dominant follicle (diameter more than 35 mm) and swollen uterus were used. In these conditions, the mares received hCG or desloreline acetate. Once ovulation occurred, the artificial insemination was carried. Two groups were performed: G1 (20 animals) received 1.5 mg desloreline acetate and G2 (20 animals) received 1700 IU of hCG. Following 6h intervals, the control follicular was performed by ultrasonography. The follicular average diameter was 42.6 cm for the groups and set up a score of 0 to 3 of uterine edema displayed by the device as well as the time of ovulation. In conclusion, the desloreline acetate showed better performance than hCG, because the ovulation was induced in less time (nine hours than hCG) (p<0.05).The pregnancy rate was 80 and 75 %, respectively in G1 and G2.
Documentos Relacionados
- Effect of equine chorionic gonadotropin (eCG) and human chorionic gonadotropin (hCG) in the post weaning fertility in primiparous and pluriparous sows
- Spatial relationships of the human chorionic gonadotropin (hCG) subunits in the assembly of the hCG-receptor complex in the luteinized rat ovary.
- Effects of human chorionic gonadotropin (hCG) on the reproductive characteristics of equine females candidates to embryo recipients
- Antibodies to bacterial vaccines demonstrating specificity for human choriogonadotropin (hCG) and immunochemical detection of hCG-like factor in subcellular bacterial fractions.
- Presence of beta hCG mRNA in the human pituitary.